MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

Xiaoman Chen,1,2,* Jing Zhou,3,* Lili Wu,1 Xiang Zhu,1 Hong Deng1 1Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China; 2Infectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical Universi...

Full description

Bibliographic Details
Main Authors: Chen X, Zhou J, Wu L, Zhu X, Deng H
Format: Article
Language:English
Published: Dove Medical Press 2022-03-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
chronic hepatitis b
metabolic associated fatty liver disease
nonalcoholic fatty liver disease
hepatitis b e antigen
Online Access:https://www.dovepress.com/mafld-is-associated-with-the-risk-of-liver-fibrosis-and-inflammatory-a-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/mafld-is-associated-with-the-risk-of-liver-fibrosis-and-inflammatory-a-peer-reviewed-fulltext-article-DMSO

Similar Items